Moderna, Inc. (MRNA)
236.50
+10.20
(+4.51%)
USD |
NASDAQ |
Oct 15, 16:00
235.00
-1.50
(-0.63%)
After-Hours: 04:11
Moderna Research and Development Expense (Quarterly) : 588.00M for June 30, 2026
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 588.00M |
| March 31, 2026 | 590.00M |
| December 31, 2025 | 708.00M |
| September 30, 2025 | 749.00M |
| June 30, 2025 | 643.00M |
| March 31, 2025 | 817.00M |
| December 31, 2024 | 1.062B |
| September 30, 2024 | 1.085B |
| June 30, 2024 | 1.18B |
| March 31, 2024 | 1.027B |
| December 31, 2023 | 1.204B |
| September 30, 2023 | 911.00M |
| June 30, 2023 | 1.058B |
| March 31, 2023 | 1.053B |
| December 31, 2022 | 1.131B |
| September 30, 2022 | 707.00M |
| June 30, 2022 | 634.00M |
| March 31, 2022 | 475.00M |
| Date | Value |
|---|---|
| December 31, 2021 | 570.00M |
| September 30, 2021 | 451.00M |
| June 30, 2021 | 352.00M |
| March 31, 2021 | 386.00M |
| December 31, 2020 | 751.15M |
| September 30, 2020 | 335.99M |
| June 30, 2020 | 144.26M |
| March 31, 2020 | 107.69M |
| December 31, 2019 | 109.82M |
| September 30, 2019 | 112.34M |
| June 30, 2019 | 120.80M |
| March 31, 2019 | 123.10M |
| December 31, 2018 | 150.43M |
| September 30, 2018 | 109.05M |
| June 30, 2018 | 104.48M |
| March 31, 2018 | 90.12M |
| December 31, 2017 | 117.83M |
| September 30, 2017 | 93.61M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Vaxcyte, Inc. | 267.85M |
| Revolution Medicines, Inc. | 392.47M |
| Sarepta Therapeutics, Inc. | 91.26M |
| Twist Bioscience Corp. | 18.02M |
| BioNTech SE | 514.38M |